Skip to main content

Perrigo Company(PRGO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Perrigo Company

THE SHARP BUILDING HOGAN PLACE
DUBLIN L2 49010 IRL
P: 353-1709-4000
http://www.perrigo.com

Profile

Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International'(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.

Key Executives

NameTitle
Patrick Lockwood TaylorCEO/Director/President

More from The Globe

25 stocks most added to Watchlists